{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T02:25:01Z","timestamp":1770431101455,"version":"3.49.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.eururo.2006.03.016","type":"journal-article","created":{"date-parts":[[2006,5,5]],"date-time":"2006-05-05T06:20:11Z","timestamp":1146810011000},"page":"235-242","source":"Crossref","is-referenced-by-count":89,"title":["Propiverine Compared to Oxybutynin in Neurogenic Detrusor Overactivity \u2013 Results of a Randomized, Double-blind, Multicenter Clinical Study"],"prefix":"10.1016","volume":"51","author":[{"given":"Manfred","family":"St\u00f6hrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerd","family":"M\u00fcrtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guus","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frieder","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin P.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Jaques","family":"Wyndaele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2006.03.016_bib1","first-page":"256","article-title":"Oxybutynin chloride in the management of idiopathic detrusor instability","volume":"6","author":"Cardozo","year":"1987","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.03.016_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0022-5347(17)38459-8","article-title":"Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo","volume":"145","author":"Thuroff","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.03.016_bib3","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0022-5347(17)45940-4","article-title":"Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia","volume":"135","author":"Gajewski","year":"1986","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.03.016_bib4","series-title":"Incontinence","first-page":"809","article-title":"Pharmacological treatment of urinary incontinence","author":"Andersson","year":"2005"},{"key":"10.1016\/j.eururo.2006.03.016_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2005.02.024","article-title":"The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis","volume":"48","author":"Chapple","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.03.016_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.ju.0000103274.38694.b1","article-title":"Can higher doses of oxybutynin improve efficacy in neurogenic bladder?","volume":"171","author":"Bennett","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.03.016_bib7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s003450100223","article-title":"Efficacy, tolerability and safety profile of propiverine in the treatment of the overactive bladder (non-neurogenic and neurogenic)","volume":"19","author":"Madersbacher","year":"2001","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2006.03.016_bib8","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1464-410x.1999.00251.x","article-title":"A placebo-controlled, multicentre study comparing the tolerability and efficacy of propiverine and oxybutynin in patients with urgency and urge incontinence","volume":"84","author":"Madersbacher","year":"1999","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.03.016_bib9","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1159\/000020221","article-title":"Efficacy and cardiac safety of propiverine in elderly patients \u2013 A double-blind, placebo-controlled clinical study","volume":"37","author":"Dorschner","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.03.016_bib10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.eururo.2005.04.023","article-title":"Propiverine versus tolterodine \u2013 efficacy and tolerability in patients with overactive bladder","volume":"48","author":"J\u00fcnemann","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.03.016_bib11","first-page":"447","article-title":"Klinische und urodynamische Effekte einer oralen Propiverintherapie bei neurogener Harninkontinenz","volume":"33","author":"Mazur","year":"1994","journal-title":"Urologe [A]"},{"key":"10.1016\/j.eururo.2006.03.016_bib12","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.sc.3100750","article-title":"Efficacy and safety of propiverine in SCI-patients suffering from detrusor hyperreflexia \u2013 a double-blind, placebo-controlled clinical trial","volume":"37","author":"St\u00f6hrer","year":"1999","journal-title":"Spinal Cord"},{"key":"10.1016\/j.eururo.2006.03.016_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodynamics"},{"key":"10.1016\/j.eururo.2006.03.016_bib14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/sc.1990.28","article-title":"The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts","volume":"28","author":"Madersbacher","year":"1990","journal-title":"Paraplegia"},{"key":"10.1016\/j.eururo.2006.03.016_bib15","article-title":"EAU Guidelines on neurogenic lower urinary tract dysfunction","author":"St\u00f6hrer","year":"2003","journal-title":"European Association of Urology"},{"key":"10.1016\/j.eururo.2006.03.016_bib16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1464-410X.2005.05344.x","article-title":"Variability of detrusor overactivity on repeated filling cystometry in men with urge symptoms: comparison with spinal cord injury patients","volume":"95","author":"Ockrim","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.03.016_bib17","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1464-410X.1995.tb07264.x","article-title":"Trospium chloride versus oxybutynin: A randomized, double-blind, multicentre trial in the treatment of detrusor hyperreflexia","volume":"75","author":"Madersbacher","year":"1995","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2006.03.016_bib18","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000282207","article-title":"Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries. A multicentre placebo-controlled double-blind trial","volume":"47","author":"St\u00f6hrer","year":"1991","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2006.03.016_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs ? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.03.016_bib20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/10790268.2004.11753751","article-title":"Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity","volume":"27","author":"Ethans","year":"2004","journal-title":"J Spinal Cord Med"},{"key":"10.1016\/j.eururo.2006.03.016_bib21","unstructured":"Madersbacher H, Menarini M, D\u00f6rsam J, Sember ME, Chiang H. Anticholinergic therapy of neurogenic detrusor overactivity: Evaluation of an oral trospium chloride (TC) dose adjustment. German Society of Urology. Poster presented at the Annual Meeting 2004."}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806003459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806003459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T16:21:17Z","timestamp":1555604477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283806003459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0302283806003459"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2006.03.016","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}